OBT: Roche and Oxford BioTherapeutics enter oncology partnership worth over $1bn
The companies will aim to discover new antibody-based therapeutics for cancer
Read full article »
OBT is a biotechnology company that focuses on the discovery and development of therapeutics for the treatment of cancer.
Read more